Aion Therapeutic Inc.

    Aion Therapeutic Inc.

    CCSE:AION
    0.01
    CAD
    0.00
    (0.00%)
    Aion Therapeutic Inc.
    CSE:AION
    (Canadian Securities Exchange)

    Recent

    price

    0.01

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -0.04
    - -
    -0.18
    -0.02
    -0.09
    -0.03
    - -
    -0.02
    -0.01
    Basic EPS, GAAP
    - -
    -0.01
    -0.12
    -0.02
    -0.04
    -0.01
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -0.01
    -0.01
    0.02
    - -
    -0.03
    -0.04
    -0.04
    -0.03
    -0.01
    Book Value per Share
    -0.01
    -0.01
    0.1
    0.06
    - -
    -0.02
    -0.02
    -0.01
    -0.01
    Tangible Book Value per Share
    35
    35
    27
    36
    94
    140
    146
    265
    478
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -324.09
    -107.43
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    -2
    - -
    -5
    -1
    -8
    -4
    - -
    -6
    -7
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1,710.9
    -451.18
    Profit Margin (%)
    - -
    - -
    2
    - -
    -1
    -2
    -3
    -4
    -5
    Working Capital
    - -
    - -
    1
    1
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    3
    2
    - -
    -2
    -3
    -4
    -5
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Jul'25
    Oct'25
    Jan'25
    ST Debt
    3
    2
    3
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    462
    497
    497
    Market Capitalization
    3
    6
    5

    Working Capital

    CAD

    •

    in mil. unless spec.
    Jul'25
    Oct'25
    Jan'25
    Total Current Assets
    1
    1
    1
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    1
    1
    - -
    Total Current Liabilities
    5
    6
    6
    Payables & Accruals
    3
    3
    3
    ST Debt
    3
    2
    3
    Deferred Revenue
    - -
    1
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -150.13%
    42.04%
    Free Cash Flow
    - -
    415.65%
    1,941.32%
    Net Income, GAAP
    - -
    648.92%
    2,349.64%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    1
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    -0.02
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business